- Home
- NVCR vs GOF Comparison
NVCR vs GOF Comparison
Compare NVCR & GOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- GOF
- Stock Information
- Founded
- NVCR 2000
- GOF 2006
- Country
- NVCR Switzerland
- GOF United States
- Employees
- NVCR N/A
- GOF N/A
- Industry
- NVCR Medical/Dental Instruments
- GOF Finance/Investors Services
- Sector
- NVCR Health Care
- GOF Finance
- Exchange
- NVCR Nasdaq
- GOF Nasdaq
- Market Cap
- NVCR 1.9B
- GOF 2.4B
- IPO Year
- NVCR 2015
- GOF N/A
- Fundamental
- Price
- NVCR $17.77
- GOF $14.95
- Analyst Decision
- NVCR Buy
- GOF
- Analyst Count
- NVCR 7
- GOF 0
- Target Price
- NVCR $32.43
- GOF N/A
- AVG Volume (30 Days)
- NVCR 1.5M
- GOF 789.2K
- Earning Date
- NVCR 07-24-2025
- GOF 01-01-0001
- Dividend Yield
- NVCR N/A
- GOF 15.42%
- EPS Growth
- NVCR N/A
- GOF N/A
- EPS
- NVCR N/A
- GOF N/A
- Revenue
- NVCR $621,711,000.00
- GOF N/A
- Revenue This Year
- NVCR $5.56
- GOF N/A
- Revenue Next Year
- NVCR $9.19
- GOF N/A
- P/E Ratio
- NVCR N/A
- GOF N/A
- Revenue Growth
- NVCR 18.27
- GOF N/A
- 52 Week Low
- NVCR $14.17
- GOF $10.96
- 52 Week High
- NVCR $34.13
- GOF $16.76
- Technical
- Relative Strength Index (RSI)
- NVCR 52.02
- GOF 60.89
- Support Level
- NVCR $16.81
- GOF $14.76
- Resistance Level
- NVCR $18.70
- GOF $14.95
- Average True Range (ATR)
- NVCR 0.73
- GOF 0.10
- MACD
- NVCR 0.04
- GOF 0.02
- Stochastic Oscillator
- NVCR 62.75
- GOF 91.84
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About GOF Guggenheim Strategic Opportunities Fund of Beneficial Interest
Guggenheim Strategic Opportunities Fund is a diversified, closed-end management investment company. The investment objective of the firm is to maximize total return through a combination of current income and capital appreciation. The Fund seeks to combine a credit-managed fixed-income portfolio with access to a diversified pool of alternative investments and equity strategies.